- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Surat Chemist Allegedly Manufactured Banned Mephedrone to Repay Forex Losses, Held

Arrested
Surat: A 28-year-old chemist in Surat allegedly began manufacturing the banned narcotic mephedrone (MD) after suffering heavy losses in foreign exchange (forex) trading, police investigations have revealed. The accused reportedly took this step to repay mounting debts, exposing a larger illegal drug manufacturing network with both local and overseas links.
Police identified the accused as Brijesh Bhalodiya, who was working as a senior chemist at a chemical manufacturing firm in the Sachin area of Surat. He was earning around ₹35,000 per month and had recently been promoted. Investigators said Bhalodiya got involved in forex trading on the advice of an acquaintance and incurred significant losses, pushing him into financial distress.
According to the probe, Bhalodiya came in contact with Janak Jagani, alleged to be the mastermind of the drug racket and currently believed to be based in London. To clear a debt of nearly ₹4 lakh owed to Jagani, Bhalodiya allegedly agreed to manufacture mephedrone. Police said he used his technical knowledge as a chemist to produce the banned substance and sent part of the proceeds to the overseas handler.
During the investigation, police found that the accused allegedly stole precursor chemicals from his employer’s factory, discreetly smuggling them out concealed in everyday items, including his tiffin box. These chemicals were then used to manufacture high-purity mephedrone at a private facility. The case came to light during a wider probe into an illegal MD laboratory that was earlier unearthed inside a mall in Surat, leading to multiple arrests and seizures of drugs and raw materials.
The investigation also brought Isha Anghan, head of Dkria Food and Pharma Analytical Laboratory, under the scanner. She allegedly allowed the use of her laboratory premises for drug production without proper verification. Police are examining her role, financial transactions and communications to determine her involvement in the illegal operation.
According to a recent media report in The Times of India, officials of the Special Operations Group (SOG) are continuing their investigation to trace the entire supply chain, including the overseas links, and to identify others involved in the manufacture and distribution of the banned drug.
Authorities have stated that further arrests are likely as the probe progresses, with a focus on dismantling the organised network behind the illegal drug manufacturing activities in the region.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

